Greg S. Martin
教授
Predictive Health Institute
Emory University;Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, School of Medicine, Emory University;The Wallace H. Coulter Department of Biomedical Engineering, Emory University;Department of Medicine, School of Medicine, Emory University
关注
立即认领
分享
关注
立即认领
分享
基本信息
浏览量:6
职业迁徙
个人简介
Research
Focus
Clinical & translational research in ARDS
I continue to study factors that influence fluid balance in the acutely injured lung, particularly as it relates to hypo-oncotic acute lung injury patients. This spans a spectrum from observational and controlled clinical trials to comparative physiology to translational biochemistry of pharmaceutical therapies. I began working in this field in the 1990s, first demonstrating an independent association between protein osmotic pressure and physiologic fluid handling capabilities, the risk of developing ARDS, and clinically important outcomes. Our group subsequently completed three randomized, blinded, controlled clinical trials testing strategies to favorably influence lung fluid balance and lung function, each demonstrating the superiority of combination colloid and diuretic therapy over diuretic therapy alone for improving oxygenation and systemic hemodynamics.
Epidemiology and health services research in sepsis
I work in the field of critical care health services research, particularly as it pertains to disparities in the risk and outcome of sepsis. Sepsis has been recognized as a clinical entity for more than a thousand years, but it was first defined in modern healthcare in 1992, which facilitated studies on sepsis epidemiology. In conjunction with colleagues at the Centers for Disease Control and Prevention (CDC), I lead the development of methods for studying the epidemiology of sepsis on both a national and a longitudinal scale. Our assessment was the first large-scale study of sepsis epidemiology in the world, particularly to demonstrate secular trends in the incidence and outcome, and also to examine important healthcare disparities that exist in the condition.
Development and validation of medical devices and point-of-care technologies
Extending our work in biomarkers, disease pathogenesis and monitoring of critically ill patients, we have led studies with invasive and non-invasive medical devices and developed the NIH-funded national Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) for validating and accelerating the market potential of point-of-care devices in broad populations of patients in both traditional healthcare settings and directly with consumers.
研究兴趣
论文共 709 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical infectious diseases : an official publication of the Infectious Diseases Society of Americano. 2 (2024): 301-307
Laurence W. Busse, Christopher L. Schaich,Mark C. Chappell,Michael T. McCurdy, Erin M. Staples,Caitlin C. Ten Lohuis,Jeremiah S. Hinson,Jonathan E. Sevransky,Richard E. Rothman,David W. Wright,Greg S. Martin,Ashish K. Khanna
Gregory L. Damhorst,Jessica Lin,Jennifer K. Frediani,Julie A. Sullivan,Adrianna Westbrook,Kaleb McLendon,Tyler J. Baugh, William H. O'Sick,John D. Roback,Anne L. Piantadosi,Jesse J. Waggoner,Leda Bassit,
Heliyonno. 6 (2024): e27188-e27188
International journal of molecular sciencesno. 9 (2023): 8152-8152
Hypertensionno. Suppl_1 (2023)
引用0浏览0引用
0
0
CIRCULATION RESEARCH (2023)
Furkan Bestepe,Colette Fritsche, Kartik Lakhotiya,Carolyn E. Niosi, George F. Ghanem,Gregory L. Martin, Ruma Pal-Ghosh,Dakota Becker-Greene,James Weston,Ivana Hollan,Ivar Risnes,Stein Erik Rynning,
Patrick R Lawler,Garen Manvelian, Alida Coppi,Amy Damask,Michael N Cantor,Manuel A R Ferreira,Charles Paulding,Nilanjana Banerjee,Dadong Li, Susan Jorgensen,Richa Attre,David J Carey,
Critical care explorationsno. 11 (2023): e0997-e0997
引用0浏览0WOS引用
0
0
CIRCULATION RESEARCHno. Suppl_1 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn